PD-1 blockade exacerbates
Animals
Bacterial Load
/ drug effects
CD4-Positive T-Lymphocytes
/ drug effects
CTLA-4 Antigen
/ metabolism
Disease Models, Animal
Humans
Immune Checkpoint Inhibitors
/ administration & dosage
Macaca mulatta
Male
Mice
Mice, Knockout
Mycobacterium tuberculosis
/ immunology
Programmed Cell Death 1 Receptor
/ antagonists & inhibitors
Severity of Illness Index
Symptom Flare Up
Tuberculosis
/ diagnosis
Journal
Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624
Informations de publication
Date de publication:
15 01 2021
15 01 2021
Historique:
received:
22
10
2020
accepted:
10
12
2020
entrez:
16
1
2021
pubmed:
17
1
2021
medline:
22
2
2022
Statut:
ppublish
Résumé
Boosting immune cell function by targeting the coinhibitory receptor PD-1 may have applications in the treatment of chronic infections. Here, we examine the role of PD-1 during
Identifiants
pubmed: 33452107
pii: 6/55/eabf3861
doi: 10.1126/sciimmunol.abf3861
pmc: PMC8300572
mid: NIHMS1712916
pii:
doi:
Substances chimiques
CTLA-4 Antigen
0
Immune Checkpoint Inhibitors
0
Programmed Cell Death 1 Receptor
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : P01 AI056299
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI112787
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI001171
Pays : United States
Informations de copyright
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Références
J Infect Dis. 2013 Jul;208(1):109-19
pubmed: 23475311
Antimicrob Agents Chemother. 2015 Jul;59(7):4181-9
pubmed: 25941223
Open Forum Infect Dis. 2020 Mar 07;7(3):ofaa067
pubmed: 32190712
Mucosal Immunol. 2018 Mar;11(2):462-473
pubmed: 28745326
Nat Rev Drug Discov. 2018 Jan;17(1):35-56
pubmed: 28935918
Am J Surg Pathol. 2006 Jul;30(7):802-10
pubmed: 16819321
Science. 2017 Mar 31;355(6332):1428-1433
pubmed: 28280247
Nature. 2009 Mar 12;458(7235):206-10
pubmed: 19078956
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Microbiome. 2017 Jul 7;5(1):71
pubmed: 28683818
Cold Spring Harb Perspect Med. 2014 Sep 11;4(12):a018564
pubmed: 25213189
Front Immunol. 2018 Aug 31;9:1995
pubmed: 30233588
Science. 2013 Nov 22;342(6161):967-70
pubmed: 24264989
J Exp Med. 2012 Dec 17;209(13):2485-99
pubmed: 23230000
J Thorac Oncol. 2016 Dec;11(12):2238-2240
pubmed: 27423391
J Vis Exp. 2017 Sep 5;(127):
pubmed: 28930979
Nature. 2006 Feb 9;439(7077):682-7
pubmed: 16382236
PLoS Pathog. 2016 Jul 13;12(7):e1005760
pubmed: 27409590
Nat Rev Immunol. 2015 Apr;15(4):255-63
pubmed: 25765201
Int J Infect Dis. 2017 Mar;56:221-228
pubmed: 28163164
N Engl J Med. 2019 Apr 25;380(17):1597-1605
pubmed: 30969503
Clin Microbiol Infect. 2018 Mar;24(3):216-218
pubmed: 29269089
mBio. 2019 Jun 4;10(3):
pubmed: 31164469
Nature. 2014 Jul 3;511(7507):99-103
pubmed: 24990750
Lancet Infect Dis. 2018 Jul;18(7):e183-e198
pubmed: 29580819
J Immunol. 2017 Nov 15;199(10):3535-3546
pubmed: 29038249
J Immunol. 2009 May 1;182(9):5430-8
pubmed: 19380790
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Elife. 2020 Feb 24;9:
pubmed: 32091388
Acta Oncol. 2016;55(4):519-20
pubmed: 26754959
Sci Rep. 2016 May 24;6:26210
pubmed: 27217330
Int Immunol. 2010 Dec;22(12):915-25
pubmed: 21047981
JCI Insight. 2018 Sep 20;3(18):
pubmed: 30232277
Sci Transl Med. 2019 Jan 16;11(475):
pubmed: 30651320
Blood. 2009 Jun 4;113(23):5811-8
pubmed: 19339692
J Clin Invest. 2012 May;122(5):1712-6
pubmed: 22523065
J Cell Death. 2010 Mar 3;3:1-11
pubmed: 21072140
J Infect Chemother. 2019 Jan;25(1):54-58
pubmed: 30055859
Science. 2018 Jan 5;359(6371):104-108
pubmed: 29302014
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13402-7
pubmed: 20624978
Immunohorizons. 2020 Jun 4;4(6):292-307
pubmed: 32499216
PLoS Comput Biol. 2013 Apr;9(4):e1003018
pubmed: 23637585
PLoS Pathog. 2016 May 31;12(5):e1005667
pubmed: 27244558
Immunity. 2014 Feb 20;40(2):235-247
pubmed: 24440150
Nat Rev Immunol. 2018 Feb;18(2):91-104
pubmed: 28990586
J Clin Invest. 2012 Aug;122(8):2967-82
pubmed: 22797302
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Methods Mol Biol. 2013;1040:103-15
pubmed: 23852600
Nat Immunol. 2009 Nov;10(11):1185-92
pubmed: 19783989
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
J Thorac Oncol. 2017 Aug;12(8):e111-e114
pubmed: 28748816
J Immunol. 2011 Feb 1;186(3):1598-607
pubmed: 21172867
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
PLoS Pathog. 2016 Mar 11;12(3):e1005490
pubmed: 26967901
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2658-63
pubmed: 18268348
Nat Immunol. 2013 Dec;14(12):1212-8
pubmed: 24240160
Nat Rev Immunol. 2018 Mar;18(3):153-167
pubmed: 28990585